Readmission rate for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Ruan H, Zhang H, Wang J, Zhao H, Han W, Li J.
Respir Med. 2023 Jan;206:107090. doi: 10.1016/j.rmed.2022.107090. Epub 2022 Dec 13.
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact.
MacLeod M, Papi A, Contoli M, Beghé B, Celli BR, Wedzicha JA, Fabbri LM.
Respirology. 2021 Jun;26(6):532-551. doi: 10.1111/resp.14041. Epub 2021 Apr 24.
Heart failure promotes multimorbidity through innate immune memory.
Nakayama Y, Fujiu K, Oshima T, Matsuda J, Sugita J, Matsubara TJ, Liu Y, Goto K, Kani K, Uchida R, Takeda N, Morita H, Xiao Y, Hayashi M, Maru Y, Hasumi E, Kojima T, Ishiguro S, Kijima Y, Yachie N, Yamazaki S, Yamamoto R, Kudo F, Nakanishi M, Iwama A, Fujiki R, Kaneda A, Ohara O, Nagai R, Manabe I, Komuro I.
Sci Immunol. 2024 May 24;9(95):eade3814. doi: 10.1126/sciimmunol.ade3814. Epub 2024 May 24.
Inpatient management of acute decompensated heart failure.
Raj L, Maidman SD, Adhyaru BB.
Postgrad Med J. 2020 Jan;96(1131):33-42. doi: 10.1136/postgradmedj-2019-136742. Epub 2019 Sep 12.
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.
Graul EL, Nordon C, Rhodes K, Marshall J, Menon S, Kallis C, Ioannides AE, Whittaker HR, Peters NS, Quint JK.
Am J Respir Crit Care Med. 2024 Apr 15;209(8):960-972. doi: 10.1164/rccm.202307-1122OC.
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease.
Roca M, Verduri A, Corbetta L, Clini E, Fabbri LM, Beghé B.
Eur J Clin Invest. 2013 May;43(5):510-21. doi: 10.1111/eci.12064. Epub 2013 Mar 12.
Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study.
Zhao X, Su R, Hu R, Chen Y, Xu X, Yuan Y, Zhang J, Zhang W, Yang Y, Chen M, Li D, Wu B, Huang D, Wu D.
BMC Geriatr. 2023 Feb 11;23(1):89. doi: 10.1186/s12877-023-03784-7.
Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.
Swart KMA, Baak BN, Lemmens L, Penning-van Beest FJA, Bengtsson C, Lobier M, Hoti F, Vojinovic D, van Burk L, Rhodes K, Garbe E, Herings RMC, Nordon C, Simons SO.
Respir Res. 2023 Nov 21;24(1):293. doi: 10.1186/s12931-023-02601-4.
Dyspnea.
Shiber JR, Santana J.
Med Clin North Am. 2006 May;90(3):453-79. doi: 10.1016/j.mcna.2005.11.006.
Risk of pharmacological treatment of anxiety and depression after admission for acute exacerbation of chronic obstructive pulmonary disease.
Hermann Karlsen J, Jacobsen PA, Kragholm K, Torp-Pedersen C, Nielsen LB, Weinreich UM.
Respir Med. 2024 May 28;229:107680. doi: 10.1016/j.rmed.2024.107680. Online ahead of print.
